Influence factors for recurrence of cytoreductive surgery in patients with epithelial ovarian cancer

SHEN Bingyan; SHEN Qian; XU Lingling

doi:10.7619/jcmp.20231817

Journal of Clinical Medicine in Practice > 2024 > 28(4): 14-18. > DOI: 10.7619/jcmp.20231817

SHEN Bingyan, SHEN Qian, XU Lingling. Influence factors for recurrence of cytoreductive surgery in patients with epithelial ovarian cancer[J]. Journal of Clinical Medicine in Practice, 2024, 28(4): 14-18. DOI: 10.7619/jcmp.20231817

Citation:

PDF (964 KB)

Influence factors for recurrence of cytoreductive surgery in patients with epithelial ovarian cancer

Department Obstetrics and Gynecology, Qidong Maternal and Child Health Care Hospital in Jiangsu Province, Qidong, Jiangsu, 226299

More Information

Received Date: June 05, 2023
Revised Date: August 01, 2023
Available Online: March 05, 2024

Graphical Abstract

Abstract

Abstract

Objective
To investigate the influence factors for recurrence of preoperative neoadjuvant chemotherapy combined with cytoreductive surgery (CRS) in treatment of patients with ovarian cancer within one year after surgery.
Methods
Ninety patients with ovarian cancer who underwent CRS treatment were selected as the study objects. Patients with ovarian cancer were followed up for one year after chemotherapy and divided into recurrence group (n=54) and no recurrence group (n=36). The general data (age, stage, etc.) and operation type (laparotomy, laparoscopy, etc.) of the two groups were compared. Then multiple regression analysis was used to analyze the independent risk factors for recurrence in patients with epithelial ovarian cancer after one year follow-up after CRS chemotherapy. The prognostic model of CRS treatment for ovarian cancer was established based on related risk factors.
Results
Before operation, the proportion of patients with high stage in the recurrence group was significantly higher than that in the no recurrence group (P < 0.05). The proportion of lymph node dissection in the no recurrence group was significantly higher than that in the recurrence group (P < 0.05). The levels of serum carbohydrate antigen 125(CA125), human epididymal protein 4(HE4), carcinoembryonic antigen (CEA) and anti-Müllerian hormone (AMH) in the recurrence group were significantly higher than those in the no recurrence group (P < 0.05). Multiple regression analysis showed that age, preoperative stage, lymph node dissection and preoperative serum CA125, HE4, CEA and AMH were all influential factors (causality) or association factors (causality) for the recurrence of CRS one year after operation in epithelial ovarian cancer patients (P < 0.05). The analysis of predictive value of CRS in patients with epithelial ovarian cancer at one year after surgery showed that the area under the curve (AUC, 95%CI) of preoperative serum CA125, HE4, CEA and AMH alone and joint prediction were 0.740 (0.516 to 0.937), 0.730 (0.467 to 0.990), 0.731 (0.477 to 0.977), 0.743 (0.515 to 0.967) and 0.884 (0.829 to 0.924), respectively.
Conclusion
Serum CA125, HE4, CEA and AMH levels should be monitored in patients with epithelial ovarian cancer during preoperative neoadjuvant chemotherapy. The AUC predicted by the combination of serum CA125, HE4, CEA, and AMH before surgery is higher than that predicted by the above indicators alone. Building a predictive risk model can improve the value of predicting the recurrence of CRS in patients with epithelial ovarian cancer within one year after surgery.

FullText(HTML)

References (19)

References

[1]	YUAN C Z, LI R R, YAN S, et al. Prognostic value of HE4 in patients with ovarian cancer[J]. Clin Chem Lab Med, 2018, 56(7): 1026-1034. doi: 10.1515/cclm-2017-1176
[2]	李可, 汪璟, 胥婧, 等. 慢性应激对卵巢癌的影响及其机制研究进展[J]. 中国实用妇科与产科杂志, 2019, 35(2): 243-246. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF201902029.htm
[3]	XU W Y, ZHANG H H, XIONG J P, et al. Prognostic significance of the fibrinogen-to-albumin ratio in gallbladder cancer patients[J]. World J Gastroenterol, 2018, 24(29): 3281-3292. doi: 10.3748/wjg.v24.i29.3281
[4]	车锋, 孙伟平, 王丽, 等. 血清白蛋白水平与脑梗死复发关系的临床研究[J]. 山西医药杂志, 2018, 47(13): 1527-1529. https://www.cnki.com.cn/Article/CJFDTOTAL-SXYY201813012.htm
[5]	CYMBALUK-PŁOSKA A, CHUDECKA-GŁAZ A, PIUS-SADOWSKA E, et al. Suitability assessment of baseline concentration of MMP3, TIMP3, HE4 and CA125 in the serum of patients with ovarian cancer[J]. J Ovarian Res, 2018, 11(1): 1. doi: 10.1186/s13048-017-0373-9
[6]	PRADJATMO H, PRADJATMO H. Impact of preoperative serum levels of CA125 on epithelial ovarian cancer survival[J]. Asian Pac J Cancer Prev, 2016, 17(4): 1881-1886. doi: 10.7314/APJCP.2016.17.4.1881
[7]	刘亚南, 高爱华, 朱维培. 上皮性卵巢癌组织中ASAP1蛋白的表达及其临床意义[J]. 江苏大学学报: 医学版, 2015, 25(6): 495-497, 502. https://www.cnki.com.cn/Article/CJFDTOTAL-ZJYZ201506008.htm
[8]	ROMAGNOLO C, LEON A E, FABRICIO A S C, et al. HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: an Italian multicenter study[J]. Gynecol Oncol, 2016, 141(2): 303-311. doi: 10.1016/j.ygyno.2016.01.016
[9]	裴益明, 王蕾, 王苗. 血清NDRG4、sB7-H4对上皮性卵巢癌患者肿瘤细胞减灭术后复发的预测价值[J]. 检验医学与临床, 2022, 19(19): 2643-2646, 2650. https://www.cnki.com.cn/Article/CJFDTOTAL-JYYL202219014.htm
[10]	王又方, 夏璇, 郁雅芳, 等. 血清miR-483-5p和miR-532-5p水平对卵巢癌手术后复发的预测价值[J]. 检验医学与临床, 2022, 19(8): 1049-1053. https://www.cnki.com.cn/Article/CJFDTOTAL-JYYL202208010.htm
[11]	蔡志芳, 沈晓青, 王丽. 奥拉帕利联合TP化疗方案对晚期卵巢癌患者血清血管形成因子和细胞凋亡因子的影响[J]. 检验医学与临床, 2022, 19(19): 2656-2659, 2663. https://www.cnki.com.cn/Article/CJFDTOTAL-JYYL202219017.htm
[12]	赵晓婷, 马玲. 预测卵巢癌复发的相关因素研究进展[J]. 蚌埠医学院学报, 2017, 42(9): 1290-1293. https://www.cnki.com.cn/Article/CJFDTOTAL-BANG201709046.htm
[13]	王喆, 张颐. 卵巢癌内分泌治疗研究进展[J]. 实用临床医药杂志, 2021, 25(13): 115-118, 128. doi: 10.7619/jcmp.20211462
[14]	何丽雅, 陈雅卿. 铂敏感复发性卵巢癌手术治疗的研究进展[J]. 肿瘤防治研究, 2021, 48(9): 903-906. https://www.cnki.com.cn/Article/CJFDTOTAL-ZLFY202109014.htm
[15]	陈燕荣, 武明娟, 刘冰, 等. 卵巢癌患者肿瘤细胞减灭术后复发的影响因素[J]. 实用临床医药杂志, 2022, 26(15): 103-108. doi: 10.7619/jcmp.20231817
[16]	LEE S, CHOI S, LEE Y, et al. Role of human epididymis protein 4 in chemoresistance and prognosis of epithelial ovarian cancer[J]. J Obstet Gynaecol Res, 2017, 43(1): 220-227. doi: 10.1111/jog.13181
[17]	李一凡, 贾晓灿, 冯宇, 等. 淋巴结切除术对早期卵巢癌预后影响的加权Cox回归分析[J]. 郑州大学学报: 医学版, 2020, 55(3): 347-351. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYK202003013.htm
[18]	韩冰, 赵倩, 海盼盼, 等. 卡铂腹腔化疗在晚期卵巢癌患者中的应用研究[J]. 中国妇产科临床杂志, 2020, 21(3): 269-271. https://www.cnki.com.cn/Article/CJFDTOTAL-FKLC202003015.htm
[19]	卢淮武, 霍楚莹, 林仲秋. 《2019NCCN卵巢癌包括输卵管癌及原发性腹膜癌临床实践指南(第1版)》解读[J]. 中国实用妇科与产科杂志, 2019, 35(5): 536-546. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGSF202402013.htm

[1]	WANG Wang, ZHAO Han. Construction of a nomogram prediction model for catheter-related bloodstream infections in hemodialysis patients with chronic renal failure[J]. Journal of Clinical Medicine in Practice, 2024, 28(18): 95-100. DOI: 10.7619/jcmp.20240464
[2]	REN Weiwei, WANG Chao, MENG Junhua, XU Suhong. Establishment and validation of an individualized risk prediction nomogram model for gestational diabetes mellitus in pregnant women with hypothyroidism[J]. Journal of Clinical Medicine in Practice, 2024, 28(16): 93-97. DOI: 10.7619/jcmp.20234265
[3]	WANG Yongxia, CHEN Xiao, LI Mei, JIANG Lijun, DING Hui. Influencing factors of dwarfism in children and construction of the nomogram model[J]. Journal of Clinical Medicine in Practice, 2024, 28(2): 92-95. DOI: 10.7619/jcmp.20232434
[4]	DENG Longlian, SUN Haibin, Enri-Letu, WANG Tengqi. Research progresses of nomogram in predicting lymph node metastasis of colorectal cancer[J]. Journal of Clinical Medicine in Practice, 2023, 27(5): 143-148. DOI: 10.7619/jcmp.20223328
[5]	ZHU Ting, ZHOU Hailan, HUA Xiaofan. Establishment and application of Nomogram model for prediction of recurrence after breast cancer surgery based on multi-dimensional indicators[J]. Journal of Clinical Medicine in Practice, 2023, 27(5): 43-48. DOI: 10.7619/jcmp.20221838
[6]	DONG Yanping, WANG Jiemin, WANG Yujin, REN Yali, DONG Yucheng, YONG Yanjun, SU Xuandi, WANG Jixiang, SU Nan, WANG Fuli, XIA Duosheng. Construction and evaluation of Nomogram prediction model for postoperative recurrence of pterygium[J]. Journal of Clinical Medicine in Practice, 2022, 26(7): 52-56. DOI: 10.7619/jcmp.20214610
[7]	WU Xin, LIANG Bo. Construction of a postoperative survival nomogram for breast cancer based on ultrasound and cancer indicators[J]. Journal of Clinical Medicine in Practice, 2021, 25(23): 62-68. DOI: 10.7619/jcmp.20213928
[8]	HU Tingting, GUO Qiu, TANG Weiwei, YANG Huan, LIU Guijun. A Nomogram model establishment for noscomial infection in elderly patients with hypertension and diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 55-60. DOI: 10.7619/jcmp.20210055
[9]	ZHANG Zhen, ZHANG Hengzhu, LI Yuping, YAN Zhengcun, DONG Lun, WANG Xiaodong, WANG Xingdong. Relationship between systemic inflammation response index and symptomatic cerebral vasospasm after aneurismal subarachnoid hemorrhage as well as construction of a Nomogram predictive model[J]. Journal of Clinical Medicine in Practice, 2020, 24(10): 36-40. DOI: 10.7619/jcmp.202010009
[10]	LI Xiuying. Clinical value of ultrasonic elastography in diagnosis of benign and malignant axillary lymph nodes in 82 cases of breast cancer[J]. Journal of Clinical Medicine in Practice, 2018, (3): 66-68. DOI: 10.7619/jcmp.201803018

Cited By

Cited by

Periodical cited type(2)

1.	李萍，徐艳芳，胡帅，曾晓霞，胡娟娟，漆学良. 热射病致吉兰-巴雷综合征三例并文献复习. 中国现代神经疾病杂志. 2024(05): 352-358 .
2.	谢霜霜，谢丹. 体外膈肌起搏器联合神经肌肉电刺激仪在ICU获得性肌无力机械通气患者中的应用. 医疗装备. 2024(24): 26-29+34 .

Other cited types(0)

Get Citation

PDF

XML

Article views (153) PDF downloads (20) Cited by(2)

Turn off MathJax

Article Contents

Abstract

References

Influence factors for recurrence of cytoreductive surgery in patients with epithelial ovarian cancer